Published in EPMA J on November 06, 2013
EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements. EPMA J (2015) 1.24
Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J (2016) 1.01
Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems. Database (Oxford) (2015) 0.89
The new holism: P4 systems medicine and the medicalization of health and life itself. Med Health Care Philos (2016) 0.83
Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer's disease. Genome Med (2014) 0.78
Does parents' socio-economic status matter in intentions of vaccinating against human papillomavirus for adolescent daughters? Afr Health Sci (2015) 0.76
ePGA: A Web-Based Information System for Translational Pharmacogenomics. PLoS One (2016) 0.75
Personalized medicine in rheumatology: the paradigm of serum autoantibodies. Auto Immun Highlights (2017) 0.75
Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models. J Alzheimers Dis (2017) 0.75
Genetics of gene expression and its effect on disease. Nature (2008) 21.35
Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science (2012) 17.12
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
Network-based classification of breast cancer metastasis. Mol Syst Biol (2007) 12.18
Variations in DNA elucidate molecular networks that cause disease. Nature (2008) 12.04
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol (2007) 5.02
Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat Biotechnol (2011) 4.03
Text mining and its potential applications in systems biology. Trends Biotechnol (2006) 3.91
Systems biology in drug discovery. Nat Biotechnol (2004) 3.29
Data-driven modelling of signal-transduction networks. Nat Rev Mol Cell Biol (2006) 3.18
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. J Clin Invest (2012) 2.33
Using electronic patient records to discover disease correlations and stratify patient cohorts. PLoS Comput Biol (2011) 2.14
Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature (1999) 2.07
Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol (2008) 1.97
The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci (2011) 1.97
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol (2012) 1.87
Biomarkers: potential uses and limitations. NeuroRx (2004) 1.86
The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med (2010) 1.86
Genome-wide association studies and beyond. Annu Rev Public Health (2010) 1.73
Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients. BMC Med Inform Decis Mak (2013) 1.66
How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol (2010) 1.60
Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks. BMC Syst Biol (2012) 1.36
Integrating pathways of Parkinson's disease in a molecular interaction map. Mol Neurobiol (2013) 1.34
Drug repositioning for personalized medicine. Genome Med (2012) 1.24
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22
Progress towards personalized medicine. Drug Discov Today (2009) 1.15
Mining literature for systems biology. Brief Bioinform (2006) 1.06
Crizotinib. Nat Rev Drug Discov (2011) 1.05
Identification of discriminating biomarkers for human disease using integrative network biology. Pac Symp Biocomput (2009) 1.01
ADO: a disease ontology representing the domain knowledge specific to Alzheimer's disease. Alzheimers Dement (2013) 0.99
Computational disease modeling - fact or fiction? BMC Syst Biol (2009) 0.98
Systems biology and the discovery of diagnostic biomarkers. Dis Markers (2010) 0.95
Challenges and opportunities for oncology biomarker discovery. Drug Discov Today (2012) 0.88
Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy. Inflamm Bowel Dis (2012) 0.86
The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment. Int J Neuropsychopharmacol (2011) 0.85
Editorial: computational methods for drug repurposing. Brief Bioinform (2011) 0.83
The biomarker is not the end. Drug Discov Today (2011) 0.83
Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome. Sci Transl Med (2011) 0.82
Has the time come for predictive computer modeling in CNS drug discovery and development? CPT Pharmacometrics Syst Pharmacol (2012) 0.80
The promises of personalized medicine. Eur J Clin Pharmacol (2010) 0.78
A novel knowledge-driven systems biology approach for phenotype prediction upon genetic intervention. IEEE/ACM Trans Comput Biol Bioinform (2011) 0.78
A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect. J Transl Med (2013) 0.77
Effective decision-making: progressing compounds through clinical development. Drug Discov Today (2001) 0.76
Detection of IUPAC and IUPAC-like chemical names. Bioinformatics (2008) 2.26
Development of a benchmark corpus to support the automatic extraction of drug-related adverse effects from medical case reports. J Biomed Inform (2012) 1.52
Identification of new drug classification terms in textual resources. Bioinformatics (2007) 1.31
Reconstruction of chemical molecules from images. Conf Proc IEEE Eng Med Biol Soc (2007) 1.28
OSIRISv1.2: a named entity recognition system for sequence variants of genes in biomedical literature. BMC Bioinformatics (2008) 1.13
Mining biomarker information in biomedical literature. BMC Med Inform Decis Mak (2012) 0.94
Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers. BMC Bioinformatics (2011) 0.94
@neuLink: a service-oriented application for biomedical knowledge discovery. Stud Health Technol Inform (2008) 0.92
Identifying gene-specific variations in biomedical text. J Bioinform Comput Biol (2007) 0.91
Concept-based semi-automatic classification of drugs. J Chem Inf Model (2009) 0.90
Challenges and opportunities for oncology biomarker discovery. Drug Discov Today (2012) 0.88
'HypothesisFinder:' a strategy for the detection of speculative statements in scientific text. PLoS Comput Biol (2013) 0.86
HuPSON: the human physiology simulation ontology. J Biomed Semantics (2013) 0.86
PLIO: an ontology for formal description of protein-ligand interactions. Bioinformatics (2011) 0.86
Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid. J Chem Inf Model (2007) 0.84
Identification of histone modifications in biomedical text for supporting epigenomic research. BMC Bioinformatics (2009) 0.82
Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space? Malar J (2006) 0.81
In silico drug discovery approaches on grid computing infrastructures. Curr Clin Pharmacol (2010) 0.80
Reasoning over genetic variance information in cause-and-effect models of neurodegenerative diseases. Brief Bioinform (2015) 0.80
WISDOM-II: screening against multiple targets implicated in malaria using computational grid infrastructures. Malar J (2009) 0.79
The @neurIST project. Stud Health Technol Inform (2008) 0.78
Alternative to consensus scoring--a new approach toward the qualitative combination of docking algorithms. J Chem Inf Model (2007) 0.78
A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect. J Transl Med (2013) 0.77
Biomarker-guided translation of brain imaging into disease pathway models. Sci Rep (2013) 0.76
Virtual high throughput screening (vHTS) on an optical high speed testbed. Stud Health Technol Inform (2008) 0.75
A robust framework for rapid deployment of a virtual screening laboratory. Stud Health Technol Inform (2009) 0.75
DockFlow - a prototypic PharmaGrid for virtual screening integrating four different docking tools. Stud Health Technol Inform (2009) 0.75